Literature DB >> 10905870

Synthesis of beta-D-Galf-(1-3)-D-GlcNAc by the trichloroacetamidate method and of beta-D-Galf-(1-6)-D-GlcNAc by SnCl4-promoted glycosylation.

C Gallo-Rodriguez1, L Gandolfi, R M de Lederkremer.   

Abstract

In a continuation of our studies on the characterization of the glycoproteins of T. cruzi new galactofuranosyl disaccharides were synthesized. Beta-D-Galf-(1-3)-D-GlcNAc was prepared by employing the trichloroacetamidate procedure for the glycosylation step. The mild conditions of this reaction are appropriate for condensation of 2,3,5,6-tetra-O-benzoyl-beta-D-galactofuranosyl trichloroacetamidate with acid-labile benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-alpha-D-glucopyranoside. On the other hand, tin(IV) chloride promoted condensation of benzyl 2-acetamido-3-O-benzoyl-2-deoxy-alpha-D-glucopyranoside with penta-O-benzoyl-alpha-beta-D-galactofuranose gave the derivative of beta-D-Galf-(1-6)-D-GlcNAc in 78% yield.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10905870     DOI: 10.1021/ol9905811

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  Trypanosoma cruzi surface mucins are involved in the attachment to the Triatoma infestans rectal ampoule.

Authors:  María de Los Milagros Cámara; Virginia Balouz; Camila Centeno Cameán; Carmen R Cori; Gustavo A Kashiwagi; Santiago A Gil; Natalia Paula Macchiaverna; Marta Victoria Cardinal; Francisco Guaimas; Maite Mabel Lobo; Rosa M de Lederkremer; Carola Gallo-Rodriguez; Carlos A Buscaglia
Journal:  PLoS Negl Trop Dis       Date:  2019-05-20

2.  Regioselectivity of glycosylation reactions of galactose acceptors: an experimental and theoretical study.

Authors:  Enrique A Del Vigo; Carlos A Stortz; Carla Marino
Journal:  Beilstein J Org Chem       Date:  2019-12-19       Impact factor: 2.883

Review 3.  Galactofuranose antigens, a target for diagnosis of fungal infections in humans.

Authors:  Carla Marino; Adriana Rinflerch; Rosa M de Lederkremer
Journal:  Future Sci OA       Date:  2017-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.